Intestinal norovirus binding patterns in non-secretor individuals

Tarris, G.; Estienney, M.; Daval-Frerot, P.; Lariotte, A.-C.; Aubignat, D.; Se, K.; Michiels, C.; Martin, L.; de Rougemont, A.; Belliot, G.

doi:10.1101/2022.05.26.493674

bioRxiv · 10.1101/2022.05.26.493674

Intestinal norovirus binding patterns in non-secretor individuals

Tarris, G.·Estienney, M.·Daval-Frerot, P.·Lariotte, A.-C.·Aubignat, D.·Se, K.·Michiels, C.·Martin, L.·de Rougemont, A.·Belliot, G.

View original source ↗Export metadata ↓

Abstract

Human norovirus (HuNoV) infection is associated with active FUT2 status, which characterizes the secretor phenotype. However, non-secretor individuals are also affected by HuNoV infection although in a lesser proportion. Here, we study GII.3, GII.4 and GII.17 HuNoV interactions in non-secretor individuals using baculovirus-expressed virus-like particles (VLPs). Only GII.4 HuNoV specifically interacted with non-secretor saliva. Competition experiments using HBGA-specific mAbs demonstrate that GII.4 VLPs recognized the Lewis a antigen (Lea). We also analyzed HuNoV VLP interactions on duodenum tissue blocks from healthy non-secretor individuals. VLP binding was observed for the three HuNoV genotypes in 10 of the 13 individuals, and competition experiments demonstrated that VLP recognition was driven by interaction with the Lea antigen. In 3 individuals, binding was restricted to either GII.4 alone or GII.3 and GII.17. One patient did not display VLP binding for any of the three genotypes. Finally, we performed a VLP binding assay on proximal and distal colon tissue blocks from a non-secretor patient with Crohns disease. VLP binding to inflammatory tissues was genotype-specific since GII.4 and GII.17 VLPs were able to interact with regenerative mucosa whereas GII.3 VLP was not. Binding of GII.4 and GII.17 HuNoV VLPs was linked to Lea in regenerative mucosae from the proximal and distal colon. Overall, our data clearly showed that Lea has a pivotal role in the recognition of HuNoV in non-secretors. We also showed that Lea is expressed in inflammatory/regenerative tissues and that it can interact with HuNoV in secretor and non-secretor individuals. The physiological and immunological consequences of such interactions in non-secretors has yet to be elucidated. IMPORTANCEHuman norovirus (HuNoV) is the main etiological agent of viral gastroenteritis in all age classes. HuNoV infection mainly affects secretor individuals, who are characterized by the presence of the ABO(H) and Lewis histo-blood group antigens at the surface of the small intestine. Non-secretor individuals, who only express Lewis antigens (Le), are less susceptible to HuNoV infection. Here we study the interaction of three frequently encountered HuNoV genotypes (GII.3, GII.4 and GII.17) in non-secretor individual using baculovirus-expressed viral particles. Preliminary saliva binding assays showed that only GII.4 interacted with non-secretor saliva via the Lea antigen. Surprisingly, in the binding assays on duodenal tissue blocks, the three genotypes interacted with non-secretor enterocytes via Lea. This suggests that HBGA status in the saliva does not necessarily reflect interactions in the intestines and, secondly, that Lea plays a pivotal role in HuNoV attachment in non-secretors. Similarly, Lea was involved in the recognition of GII.4 and GII.17 HuNoV particles by inflammatory colon tissue from a non-secretor Crohns disease patient. The molecular implications of HuNoV binding in non-secretors remains to be elucidated in physiological and pathological conditions encountered in other intestinal diseases.

Explore related subjects

microbiology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Tarris, G., Estienney, M., Daval-Frerot, P., Lariotte, A.-C., Aubignat, D., Se, K., Michiels, C., Martin, L., de Rougemont, A., Belliot, G.. 2022-05-28. Intestinal norovirus binding patterns in non-secretor individuals. https://doi.org/10.1101/2022.05.26.493674

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

bioRxiv2026

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

bioRxiv2026

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗